Accretion Nutrav

Which are the latest news on Accretion Nutrav?

Why is Accretion Nutraveda Ltd falling/rising?

As of 05-Sep, the stock price of Accretion Nutraveda Ltd is at 276.00, unchanged. The stock has declined over the past week and month, showing reduced investor participation and mixed moving average signals, indicating stagnation in its price.

As of 05-Sep, the stock price of Accretion Nutraveda Ltd is currently at 276.00, showing no change (0.00%). Over the past week, the stock has declined by 2.09%, which is a larger drop compared to the Sensex's decrease of 0.97%. In the past month, the stock has fallen by 2.65%, while the Sensex has decreased by 2.44%. <BR><BR>Despite today's performance indicating that the stock has outperformed its sector by 0.45%, there are signs of declining investor participation, as evidenced by a delivery volume of 3,000 shares on September 3, which represents a 28.57% drop compared to the 5-day average. Additionally, while the stock is trading above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day moving averages, suggesting a short-term weakness. <BR><BR>Overall, the combination of recent declines in stock performance relative to the benchmark, reduced investor participation, and mixed moving average signals contribute to the current stagnation in the stock price of Accretion Nutraveda Ltd.

What does Accretion Nutrav do?

Accretion Nutraveda Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology sector, incorporated in 2021 and converted to a Public Limited Company in 2025. It has a market cap of INR 204 Cr, with a P/E ratio of 39.00 and no available revenue or profit data for the latest quarter.

Overview:<BR>Accretion Nutraveda Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>Accretion Nutraveda Ltd was incorporated as a Private Limited Company on March 16, 2021, and later converted to a Public Limited Company on May 2, 2025. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 204 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 39.00<BR>Industry P/E: 37<BR>Dividend Yield: 0.00%<BR>Debt Equity: -0.17<BR>Return on Equity: 16.06%<BR>Price to Book: 6.47<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the peers of the Accretion Nutrav?

Accretion Nutrav's peers include Natural Capsules, Sanjiv.Parant., Oxygenta Pharma, Brooks Lab., CCME Global, Syschem (India), Sat Kartar Life, and Accretion Pha. Among them, Sanjiv.Parant. and Sat Kartar Life show excellent management and growth, while Brooks Lab. has the lowest 1-year return at -51.79%.

Peers: The peers of Accretion Nutrav are Natural Capsules, Sanjiv.Parant., Oxygenta Pharma, Brooks Lab., CCME Global, Syschem (India), Sat Kartar Life, and Accretion Pha.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sanjiv.Parant. and Sat Kartar Life, while Good management risk is found at Accretion Pha. and the rest. Below Average management risk is noted at Natural Capsules, Brooks Lab., CCME Global, and Syschem (India). Excellent growth is seen at Sanjiv.Parant. and Sat Kartar Life, while Good growth is noted at Syschem (India) and Accretion Pha., and the rest show Below Average growth. Excellent capital structure is present at Sanjiv.Parant. and Sat Kartar Life, while Good capital structure is found at CCME Global and Accretion Pha., and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sat Kartar Life at 0.00%, while Brooks Lab. has the lowest at -51.79%. Accretion Nutrav's 1-year return is not available for comparison. Additionally, CCME Global, Syschem (India), and Brooks Lab. have negative six-month returns.

How big is Accretion Nutrav?

As of 31st August, Accretion Nutraveda Ltd has a market capitalization of 204.00 Cr, classified as a Micro Cap, with no valid financial data available for Net Sales and Net Profit for the latest four quarters. Shareholder's Funds are 35.47 Cr and Total Assets are 41.78 Cr as of March 2026.

As of 31st August, <BR><BR>Market Cap: Accretion Nutraveda Ltd has a market capitalization of 204.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2026, with Shareholder's Funds amounting to 35.47 Cr and Total Assets totaling 41.78 Cr.

When is the next results date for Accretion Nutraveda Ltd?

The next results date for Accretion Nutraveda Ltd is 08 May 2026.

The next results date for Accretion Nutraveda Ltd is scheduled for 08 May 2026.